skip navigation
National Cancer Institute   U.S. National Institutes of Healthwww.cancer.gov
Rapid Response Surveillance Studies
Contact Us
   
 Home
   
 Methodologic Issues
   
 Cancer Treatment & Outcomes
   
 Monitoring Screening Practices
   
 Health Behaviors & Risk Factors
   
 Linking Databases
   
 Technical Aspects of Registry Operations
   
 Publications
   

Publications - Secondary/Late Effects of Treatment

View the description of these studies.

2005

Hoffman RM, Barry MJ, Stanford JL, Hamilton AS, Hunt WC, Collins MM. Health Outcomes in Older Men with Localized Prostate Cancer. Am J Med

Klabunde CN, Reeve BB, Harlan LC, Davis WW, Potosky AL. Do patients consistently report comorbid conditions over time? Med Care 2005 Apr;43(4):391-400.

Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD, Hamilton A, Hoffman RM, Stephenson RA, Potosky AL and Stanford JL. 5-year urinary and sexual outcomes after radical prostatectomy. Journal of Urology 2005 May; 173(5): 1701-5

Stephenson RA, Mori M, Hsieh Y-C, Beer TM, Stanford JL, et al. Treatment of Erectile Dysfunction Following Therapy for Clinically Localized Prostate Cancer. J Urol 2005;174:646-650

2004

Johnson TK, Gilliland FD, Hoffman RM et al. Racial/Ethnic differences in functional outcomes in the 5 years after diagnosis of localized prostate cancer. J Clin Oncol 2004 22:4193-201.

Potosky AL, Davis W, Hoffman RM, Stanford J, Stephenson R, Penson D, Harlan LC. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer. Journal of the National Cancer Institute 2004;96(18):1358-67.

2003

Hoffman RM, Harlan LC, Klabunde CN, Gilliland F, Stephenson R, Hunt W, Potosky AL. Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study. Journal of General Internal Medicine 2003;18(10):845-853.

Hoffman RM, Hunt WC, Gilliland FD, Stephenson RA, Hamilton AS, Stone SN, Potosky AL. Satisfaction with treatment decisions for clinically localized prostate cancer. Cancer 2003; 97:1653-62.

Hoffman RM, Stone SN, Hunt WC, Key CR, Gilliland FD. Effects of misattribution in assigning cause of death on prostate cancer mortality rates. Ann Epidemiol 2003; 13:450-4.

Penson D, Feng Z, Kuniyuki A, McClearran D, Albertsen PC, Deapen D, Gilliland F, Hoffman RM, Stephenson R, Potosky AL, Stanford J. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. Journal of Clinical Oncology 2003;21(6):1147-1154.

2002

Potosky AL, Reeve Bs, Clegg L, Hoffman RM, Stephenson R, Albertsen PC, Gilliland F, Stanford J. Quality of Life Following Localized Prostate Cancer Treated Initially with Androgen Deprivation Therapy or No Therapy. Journal of the National Cancer Institute 2002;94:430-437.

2001

Clegg, L, Potosky AL, Harlan LC, Hankey B, Hoffman R, Stanford J, Hamilton AS. Comparison of self-reported initial treatment with medical records: Results for the Prostate Cancer Outcomes Study. Journal of American Epidemiology 2001; 154: 582-587.

Hamilton A, Stanford J, Gilliland F, Albertsen P, Stephenson R, Hoffman R, Eley B, Harlan L, and Potosky A, Health Outcomes after External Beam Radiation Therapy for Clinically Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study. Journal of Clinical Oncology 2001; 19(9): 2517-26.

Harlan LC, Potosky AP, Gilliland FD, Hoffman R, Albertsen, PC, Hamilton A, Eley JW, Stanford JL, Stephenson RA. Factors Associated with Initial Therapy for Clinically Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study. Journal of the National Cancer Institute2001; 93:1864-1871.

Hoffman RM, Gilliland FD, Eley JW, Harlan LC, Stephenson RA, Stanford JL, Albertsen PC, Hunt WC, Potosky AL. Racial and Ethnic Differences in Advanced-Stage Prostate Cancer: the Prostate Cancer Outcomes Study. Journal of the National Cancer Institute 2001;93:388-395.

Potosky AL, Knopf K, Clegg LX, Albertsen PC, Stanford JL, Hamilton AS, Gilliland FD, Eley JW, Stephenson RA, Hoffman RM. Quality-of-life outcomes after primary androgen deprivation therapy: Results from the Prostate Cancer Outcomes Study Journal of Clinical Oncology 2001; 19(17)3750-57.

2000

Albertsen PC, Hanley JA, Harlan LC, Gilliland F, Hamilton AS, Liff HM, Stanford HL, Stephenson R. The Positive Yield of Imaging Studies in the Evaluation of Men with Newly Diagnosed Prostate Cancer: A Population-Based Analysis. Journal of Urology 2000;163:1138-1143.

Legler JM, Potosky AL, Gilliland FD, Eley JW, Stanford JL. Validation study of retrospective recall of disease-specific function. Medical Care 2000;38(8):847-857.

Potosky AL, Legler J, Albertsen PC, Stanford JL, Gilliland FD, Hamilton AS, Eley JW, Stephenson RA, Harlan LC. Health Outcomes After Prostatectomy or Radiotherapy For Prostate Cancer: Results from the Prostate Cancer Outcomes Study. Journal of the National Cancer Institute 2000; 92(19):1582-92.

Stanford J, Feng Z, Hamilton AS, Gilliland F, Stephenson R, Eley JW, Albertsen PC, Harlan LC, Potosky AL. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study. Journal of the American Medical Association 2000;283(3):354-360.

1999

El-Bastawissi AY, Becker TM, Daling JR. Effect of cervical carcinoma in situ and its management on pregnancy outcome. Obstetrics and gynecology 1999 Feb;93(2):207-212.

Gilliland F, Hoffman RM, Hamilton AS, Albertsen PC, Eley JW, Harlan LC, Stanford J, Hunt WC, Potosky AL. Predicting extracapsular extension of prostate cancer in men treated with radical prostatectomy: results from the population based Prostate Cancer Outcomes Study. Journal of Urology 1999;162(4):1341-45.

Hoffman RM, Gilliland FD. A population-based survey of prostate cancer screening in New Mexico. Journal of Community Health 1999; 24: 409-19.

Potosky AL, Harlan LC, Stanford J, Gilliland F, Hamilton AS, Albertsen PC, Eley JW, Liff J, Deapen D, Stephenson R, Legler JM, Ferrans CE, Talcott JA, Litwin MS. Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. Journal of the National Cancer Institute 1999;91(20):1719-1724.

1998

Gilliland FD, Hunt WC, Key CR. Trends in the survival of American Indian, Hispanic, and Non-Hispanic white cancer patients in New Mexico and Arizona, 1969-1994. Cancer 1998 82(9):1769-83.

Gilliland FD, Key CR. Prostate cancer in American Indians, New Mexico, 1969 to 1994. Journal of Urology. 1998 159(3):893-7.

Hoffman RM, Blume P, Gilliland F. Prostate-Specific Antigen Testing Practices and Outcomes in a Primary Care Clinic. Journal of General Internal Medicine 1998;13:106-10.

Privacy Policy Accessibility Contact Us
National Cancer Institute    Department of Health and Human Services     National Institutes of Health    USA.gov